Proffitt & Goodson’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $175K | Sell |
943
-4
| -0.4% | -$742 | 0.03% | 108 |
|
|
2025
Q1 | $198K | Hold |
947
| – | – | 0.03% | 108 |
|
|
2024
Q4 | $168K | Sell |
947
-23
| -2% | -$4.09K | 0.03% | 111 |
|
|
2024
Q3 | $192K | Buy |
970
+23
| +2% | +$4.54K | 0.03% | 110 |
|
|
2024
Q2 | $162K | Hold |
947
| – | – | 0.03% | 114 |
|
|
2024
Q1 | $172K | Sell |
947
-244
| -20% | -$44.4K | 0.03% | 112 |
|
|
2023
Q4 | $185K | Hold |
1,191
| – | – | 0.03% | 108 |
|
|
2023
Q3 | $178K | Hold |
1,191
| – | – | 0.04% | 106 |
|
|
2023
Q2 | $160K | Hold |
1,191
| – | – | 0.03% | 112 |
|
|
2023
Q1 | $190K | Hold |
1,191
| – | – | 0.04% | 110 |
|
|
2022
Q4 | $192K | Hold |
1,191
| – | – | 0.04% | 110 |
|
|
2022
Q3 | $160K | Hold |
1,191
| – | – | 0.03% | 113 |
|
|
2022
Q2 | $182K | Hold |
1,191
| – | – | 0.04% | 112 |
|
|
2022
Q1 | $193K | Buy |
1,191
+306
| +35% | +$49.6K | 0.04% | 114 |
|
|
2021
Q4 | $120K | Hold |
885
| – | – | 0.02% | 123 |
|
|
2021
Q3 | $95K | Hold |
885
| – | – | 0.02% | 133 |
|
|
2021
Q2 | $100K | Hold |
885
| – | – | 0.02% | 128 |
|
|
2021
Q1 | $96K | Hold |
885
| – | – | 0.02% | 130 |
|
|
2020
Q4 | $95K | Hold |
885
| – | – | 0.02% | 127 |
|
|
2020
Q3 | $78K | Buy |
885
+120
| +16% | +$10.6K | 0.02% | 125 |
|
|
2020
Q2 | $75K | Hold |
765
| – | – | 0.02% | 123 |
|
|
2020
Q1 | $58K | Hold |
765
| – | – | 0.02% | 112 |
|
|
2019
Q4 | $68K | Buy |
+765
| New | +$68K | 0.02% | 117 |
|
|
2019
Q3 | – | Sell |
-1,160
| Closed | -$84K | – | 209 |
|
|
2019
Q2 | $84K | Hold |
1,160
| – | – | 0.02% | 115 |
|
|
2019
Q1 | $93K | Buy |
+1,160
| New | +$93K | 0.02% | 107 |
|